Arexvy Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Resp syncytial virus (RSV) vaccine (recombinant, adjuvanted) (RSVPreF3 antigen, AS01_E adjuvant system)

Indications/Uses

Active immunisation for prevention of lower resp tract disease caused by RSV in adults ≥60 yr.

Click to view Arexvy detailed prescribing information

Dosage/Direction for Use

IM Single dose of 0.5 mL inj.

Click to view Arexvy detailed prescribing information

Overdosage

View Arexvy overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Arexvy detailed prescribing information

Special Precautions

Always administer at different inj sites if to be given at the same time as another injectable vaccine. Closely observe for at least 15 min following vaccination in case of anaphylactic event. Postpone vaccination in individuals suffering from acute severe febrile illness. Do not administer intravascularly or intradermally. Caution in individuals w/ thrombocytopenia or any coagulation disorder following IM administration. Patients receiving immunosuppressive treatment or those w/ immunodeficiency may have reduced immune response to Arexvy. Minor influence on ability to drive & use machines. Not recommended during pregnancy & in breast-feeding/lactating women. Safety & efficacy in childn have not been established.

Click to view Arexvy detailed prescribing information

Use In Pregnancy & Lactation

Click to view Arexvy detailed prescribing information

Adverse Reactions

Headache; myalgia, arthralgia; inj site pain, fatigue. Inj site erythema or swelling, fever, chills.

Click to view Arexvy detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Arexvy detailed prescribing information

Storage

View Arexvy storage conditions for details to ensure optimal shelf-life.

Description

View Arexvy description for details of the chemical structure and excipients (inactive components).

Action

View Arexvy mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BX05 - respiratory syncytial virus vaccines ; Belongs to the class of other viral vaccines. Used for active immunization against respiratory syncytial virus.

Regulatory Classification

Presentation/Packing

Form

Arexvy powd for susp for inj 120 mcg/0.5 mL

Packing/Price

(1 vial of antigen powd + 1 vial of adjuvant susp) 1's

Arexvy

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline Biologicals

Distributor:

GlaxoSmithKline